Idorsia today
More in the
pipeline –
Promising
compounds
More science – Bursting with ideas
Idorsia began its operations after the demerger from Actelion on June 15, 2017, with registered shares of Idorsia Ltd being listed on the SIX Swiss Exchange the following day. Today, Idorsia has an experienced team of highly qualified professionals, a full R&D pipeline, state-of-the-art facilities, and a healthy balance sheet – the ideal constellation for bringing successful medicines to the market.
Idorsia is so much more than a start-up!
Our Strategy
Find out more about how Idorsia intends to deliver on its ambitious goals.
Idorsia pipeline
See an overview of Idorsia's clinical development pipeline.
History
Learn more about how Idorsia came to life.